Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP316617.RAVZrG2cosDZtbHLgizbuLhg9F3N0pdob7pUJaM2sSgzg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP316617.RAVZrG2cosDZtbHLgizbuLhg9F3N0pdob7pUJaM2sSgzg130_assertion type Assertion NP316617.RAVZrG2cosDZtbHLgizbuLhg9F3N0pdob7pUJaM2sSgzg130_head.
- NP316617.RAVZrG2cosDZtbHLgizbuLhg9F3N0pdob7pUJaM2sSgzg130_assertion wasGeneratedBy ECO_0000203 NP316617.RAVZrG2cosDZtbHLgizbuLhg9F3N0pdob7pUJaM2sSgzg130_provenance.
- NP316617.RAVZrG2cosDZtbHLgizbuLhg9F3N0pdob7pUJaM2sSgzg130_assertion wasDerivedFrom befree-20140225 NP316617.RAVZrG2cosDZtbHLgizbuLhg9F3N0pdob7pUJaM2sSgzg130_provenance.
- NP316617.RAVZrG2cosDZtbHLgizbuLhg9F3N0pdob7pUJaM2sSgzg130_assertion SIO_000772 20813562 NP316617.RAVZrG2cosDZtbHLgizbuLhg9F3N0pdob7pUJaM2sSgzg130_provenance.
- NP316617.RAVZrG2cosDZtbHLgizbuLhg9F3N0pdob7pUJaM2sSgzg130_assertion evidence source_evidence_literature NP316617.RAVZrG2cosDZtbHLgizbuLhg9F3N0pdob7pUJaM2sSgzg130_provenance.
- NP316617.RAVZrG2cosDZtbHLgizbuLhg9F3N0pdob7pUJaM2sSgzg130_assertion description "[Our study supports that mutations in the BRAF, KRAS, and PIK3CA genes make at least a minor contribution to OSCC tumorigenesis, and pathway-specific therapies targeting these 2 pathways should be considered for OSCC in a subset of patients with these mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316617.RAVZrG2cosDZtbHLgizbuLhg9F3N0pdob7pUJaM2sSgzg130_provenance.